Searcharxiv⌕ Search

arXiv · 2611.13190

EvoSurv: Evolution-Aware Multimodal Survival Modeling Reveals Complementary Prognostic Signals

Abstract

Accurate cancer survival prediction remains challenging due to tumor heterogeneity. Although multimodal survival models integrate clinical and molecular data, they often overlook evolutionary information encoded in genomic alterations. To address this gap, we developed eTime, a 38-dimensional evolutionary representation comprising eight feature groups that characterize clonal and subclonal mutation burden, mutational spectra, functional consequences, copy-number alterations, and anoikis-related genomic changes. We further developed EvoSurv, a multimodal survival framework integrating eTime with clinical variables and RNA expression. Across six TCGA cancer cohorts comprising 2,782 patients, EvoSurv achieved the highest mean concordance index (C-index) in all six cancers, averaging 0.663 and outperforming three state-of-the-art survival prediction methods. More importantly, we assessed whether evolutionary features provide additional prognostic information beyond clinical and transcriptomic predictors. eTime remained significantly associated with survival in head and neck squamous cell carcinoma (HNSC) and liver hepatocellular carcinoma (LIHC) after adjustment for clinical variables and RNA-derived risk scores. Feature-group analyses further revealed cancer-specific prognostic patterns. In HNSC, T>G substitutions were associated with increased mortality risk after clinical and molecular adjustment, including in HPV-negative patients, with supporting evidence from an independent CPTAC-HNSCC cohort. Overall, these findings demonstrate that eTime captures survival-associated evolutionary information and highlight its potential to provide prognostic value beyond clinical and transcriptomic predictors.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Wei Wang, Po-Yu Liang, Jun Bai. 2026-11-09. EvoSurv: Evolution-Aware Multimodal Survival Modeling Reveals Complementary Prognostic Signals. https://searcharxiv.com/abs/2611.13190

Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite Searcharxiv by Indiciae: BibTeX · RIS.

KEEP EXPLORING

Related papers

Optimising Recruitment and Sample Allocation in Multi-Site Rare Disease Studies

Clinical research in rare diseases is challenged by the limited availability and broad geographical distribution of eligible patients. This necessitates multi-centre collaboration and strategic selection of analytical laboratories based on capacity, cost, and capability. We present a mathematical framework based on cardinality optimisation to support key operational decisions in study design, balancing clinical relevance, feasibility, budgetary constraints, and logistical factors. The framework was implemented in the Reconstruction and Computational Modelling for Inherited Metabolic Diseases (Recon4IMD) project, aiming to recruit 1,900 diagnosed patients across 24 healthcare centres and eight metabolomic laboratories. Compared to both proportional heuristic and greedy marginal allocation baselines, the proposed optimisation model consistently achieved higher recruitment yields in simulated multi-centre scenarios and reduced metabolomic analysis costs by approximately 30% under unconstrained conditions. Notably, both the heuristic and greedy allocation baselines became infeasible under progressively tighter laboratory capacity constraints, whereas the optimised model maintained feasibility and cost control. These findings highlight the value of integrated optimisation strategies for improving recruitment, platform selection, and sample allocation in complex, resource-limited research settings.

q-bio.QM↗

Analysis choices can produce apparent rich-club differences: an Alzheimer's disease EEG case study

Background: The weighted rich-club coefficient tests whether a network's most strongly connected nodes are preferentially interconnected. Its interpretation depends on two often-implicit choices: how the randomised comparison networks are constructed, and whether the hubs are re-identified in each comparison network or held fixed at those of the observed network. When hubs are defined by connection strength, these choices change what the coefficient tests. New method: We examined how these choices affect inference using resting-state EEG from 20 people with Alzheimer's disease and 20 controls. Holding the data fixed, we compared four analysis pipelines, crossing two ways of building the comparison networks (global weight reshuffle or strength-conditioned null) with the two hub choices, and ran a calibration study using data constructed to contain no preferential hub coupling beyond nodal strength. Results: An apparent eyes-open group difference in rich-club organisation appeared only under the pipeline combining a global weight reshuffle with re-identified hubs. Under the empirical resampling ensemble, that pipeline reported a group difference in 43% of pseudo-studies, always higher in the Alzheimer's disease group, while the other three stayed near the expected 5%. Comparison with existing methods: Unlike global weight reshuffling, strength-conditioned nulls approximately preserve nodal strengths; fixing observed hubs also retains the identity of the core being tested. Conclusions: The same data can support or dissolve an apparent rich-club difference depending on these choices. No single choice is universally correct, but reporting which were made, and why they fit the question being asked, is essential to interpreting the result.

q-bio.QM↗

Quantum Cognition Machine Learning for Forecasting Chromosomal Instability

The accurate prediction of chromosomal instability from the morphology of circulating tumor cells (CTCs) enables real-time detection of CTCs with high metastatic potential in the context of liquid biopsy diagnostics. However, it presents a significant challenge due to the high dimensionality and complexity of single-cell digital pathology data. Here, we introduce the application of Quantum Cognition Machine Learning (QCML), a quantum-inspired computational framework, to estimate morphology-predicted chromosomal instability in CTCs from patients with metastatic breast cancer. QCML leverages quantum mechanical principles to represent data as state vectors in a Hilbert space, enabling context-aware feature modeling, dimensionality reduction, and enhanced generalization without requiring curated feature selection. QCML outperforms conventional machine learning methods when tested on out of sample verification CTCs, achieving higher accuracy in identifying predicted large-scale state transitions (pLST) status from CTC-derived morphology features. These preliminary findings support the application of QCML as a novel machine learning tool with superior performance in high-dimensional, low-sample-size biomedical contexts. QCML enables the simulation of cognition-like learning for the identification of biologically meaningful prediction of chromosomal instability from CTC morphology, offering a novel tool for CTC classification in liquid biopsy.

q-bio.QM↗